Interim report, foreign filer
Open the filing on sec.gov
Ascentage Pharma Group International American Depository Shares (AAPG)
Nasdaq: AAPG · Pharmaceutical Preparations · Suzhou , Jiangsu, CN · filing with the SEC since 2024
The companyfiscal 2024, as filed
RevenueCN¥981M+341.8%
Net income-CN¥406M+56.2%
Earnings per shareCN¥-1.34+59.1%
Operating cash flow-CN¥111M+84.7%
CashCN¥893M-14.0%
DebtCN¥1.67B-7.1%
Shareholders’ equityCN¥274M+288.2%
Shares, diluted302.1M+7.0%
Return on equityn/a
The recordfrom its filings
Filings in 202665
Newest filingNov 5 · 6-K
Annual reportApr 29, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted2
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in CNY. Nothing here is a forecast.
News
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.